Skip to main content
SpringerLink
Log in

Hypertension

  • Reference work entry
Encyclopedia of Heart Diseases

  • 1521 Accesses

Overview

Hypertension, commonly known as high blood pressure, is a problem suffered by more than one billion individuals worldwide and more than 60 million people in the United States mainly from the age of 50 to 80. The prevalence of hypertension in developed countries is about the same as observed in the U.S. white population.

The complications of high blood pressure often lead to stroke, heart attack, heart failure, kidney failure, and a common bothersome arrhythmia, atrial fibrillation, all of which pose serious physical handicaps. There are generally very few symptoms associated with high blood pressure. Mild transient dizziness and mild short duration headaches may occur in some patients but generally health complaints may not surface for 10–20 years, thus the term “the silent killer.”

Blood pressure is the pressure exerted by the blood against the inner walls of arteries (Blood Pressure). An individual’s blood pressure normally fluctuates from 5 to 15 mmHg from minute to...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 679.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 699.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

References

  • Äblad B, Bjurö T, Björkman JA, Edström T, Olsson G (1991) Role of central nervous beta-adrenoceptors in the prevention of ventricular fibrillation through augmentation of cardiac vagal tone. J Am Coll Cardiol 17(Suppl):165

    Article  Google Scholar 

  • Bangalore S, Messerli F, Kostis J, Pepine C (2007) Cardiovascular protection using beta-blockers: a critical review of the evidence. J Am Coll Cardiol 50:563–572

    Article  CAS  PubMed  Google Scholar 

  • Beckett NS, Peters R, Fletcher AE et al For the HYVET Study Group (2008) Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358:1887–1898. HYVET

    Google Scholar 

  • Borhani NO, Mercury M, Borhani PA et al (1996) Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS): a randomised controlled trial. JAMA 276:785

    Article  CAS  PubMed  Google Scholar 

  • Bos WJW, Imholz BPM, van Montfrans GA et al (1992a) The reliability of non invasive continuous finger blood pressure measurements in patients with both hypertension and vascular disease. Am J Hypertens 5:529–535

    CAS  PubMed  Google Scholar 

  • Bos WJW, van Goudoever J, van Montfrans GA et al (1992b) Influence of short term blood pressure variability on blood pressure determinations. Hypertension 19:606–609

    CAS  PubMed  Google Scholar 

  • Boydak B, Nalbantgil S, Fici F et al (2005) A randomised comparison of the effects of nebivolol and atenolol with and without chlorthalidone on the sexual function of hypertensive men. Clin Drug Investig 25:409–416

    Article  CAS  PubMed  Google Scholar 

  • Bramlage P, Pittrow D, Wittchen H-U, Kirch W, Boehler S, Lehnert H, Hoefler M, Unger T, Sharma AM (2004) Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens 17:904–910

    Article  PubMed  Google Scholar 

  • Brixius K, Middeke M, Lichtenthal A, Jahn E, Schwinger RH (2007) Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men. Clin Exp Pharmacol Physiol 34:327–331

    Article  CAS  PubMed  Google Scholar 

  • Broeders M, Doevendans P, Bekkers B et al (2000) Nebivolol: a third-generation ß-blocker that augments vascular nitric oxide release. Circulation 102:877–884

    Google Scholar 

  • Brown MA, Buddle ML, Martin A (2001) Is resistant hypertension really resistant? Am J Hypertens 14:1263–1269

    Article  CAS  PubMed  Google Scholar 

  • Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P (2002) Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40:892–896

    Article  CAS  PubMed  Google Scholar 

  • Calhoun DA, Jones D, Textor S et al (2008) AHA scientific statement: resistant hypertension: diagnosis, evaluation, and treatment. Circulation 117:e510–e526

    Article  PubMed  Google Scholar 

  • Caskey FJ, Thacker EJ, Johnston PA et al (1997) Failure of losartan to control blood pressure in scleroderma renal crisis. Lancet 349:620

    Article  CAS  PubMed  Google Scholar 

  • Chen TM, Chiou WL (1992) Large differences in the biological half-life and volume of distribution of hydrochlorothiazide in normal subjects from eleven studies Correlation with their last blood sampling times. Int J Clin Pharmacol Ther Toxicol 30:34–37

    CAS  PubMed  Google Scholar 

  • Chobanian AV (2008) Does it matter how hypertension is controlled? N Engl J Med 359:2485–2488

    Article  CAS  PubMed  Google Scholar 

  • Cockroft JR, Chowienczyk PJ, Brett SE et al (1995) Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism. J Pharmacol Exp Ther 274:1067–1071

    Google Scholar 

  • Cominacini L, Fratta PA, Garbin U et al (2003) Nebivolol and its 4-keto derivative increase nitric oxide in endothelial cells by reducing its oxidative inactivation. J Am College Cardiol 42:1838–1844

    Article  CAS  Google Scholar 

  • Cruickshank JM (2009) Beta-blockers in the treatment of hypertension. BMJ 338:b1665

    Article  Google Scholar 

  • Davis BR, Kostis JB, Simpson LM et al (2008) Heart failure with preserved and reduced left ventricular ejection fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial for the ALLHAT Collaborative Research Group. Circulation 118:2259–2267

    Article  CAS  PubMed  Google Scholar 

  • Deary A, Schumann AL, Murfet H (2002) Double-blind placebo-controlled crossover comparison of five classes of antihypertensive drugs. J Hypertens 20:771–777

    Article  PubMed  Google Scholar 

  • Dellow EL, Unwin RJ, Honour JW (1999) Pontefract cakes can be bad for you: refractory hypertension and liquorice excess. Nephrol Dial Transplant 14:218–220

    Article  CAS  PubMed  Google Scholar 

  • Dickerson JEC, Hingorani AD, Ashby MJ et al (1999) Randomisation of antihypertensive treatment by crossover rotation of four major classes. Lancet 353:2008–2013

    Article  CAS  PubMed  Google Scholar 

  • Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A, Hauner H, McCann SM, Scherbaum WA, Bornstein SR (2003) Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci USA 100:14211–14216

    Article  CAS  PubMed  Google Scholar 

  • Eide IK, Torjesen PA, Drolsum A, Babovic A, Lilledahl NP (2004) Low-renin status in therapy-resistant hypertension: a clue to efficient treatment. J Hypertens 22:2217–2226

    Article  CAS  PubMed  Google Scholar 

  • Engeli S, Böhnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC, Sharma AM (2005) Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45:356–362

    Article  CAS  PubMed  Google Scholar 

  • Ernst ME, Carter BL, Goerdt CJ et al (2006) Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 47:352–358

    Article  CAS  PubMed  Google Scholar 

  • Estacio RO, Jeffers BW, Hiatt WR et al (1998) The effects of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with noninsulin dependent diabetes and hypertension. N Engl J Med 338:645

    Article  CAS  PubMed  Google Scholar 

  • Fardella CE, Mosso L, Gómez-Sánchez C, Cortés P, Soto J, Gómez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J (2000) Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 85:1863–1867

    Article  CAS  PubMed  Google Scholar 

  • Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC (2001) Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis 37:699–705

    Article  CAS  PubMed  Google Scholar 

  • Garg JP, Elliott WJ, Folker A, Izhar M, Black HR (2005) For the RUSH Hypertension Service. Resistant hypertension revisited: a comparison of 2 university-based cohorts. Am J Hypertens 18:619–626

    Article  PubMed  Google Scholar 

  • Goodfriend TL, Ball DL, Gardner HW (2002) An oxidized derivative of linoleic acid affects aldosterone secretion by adrenal cells in vitro. Prostaglandins Leukot Essent Fatty Acids 67:163–167

    Article  CAS  PubMed  Google Scholar 

  • Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC (1994) High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21:315–318

    Article  CAS  PubMed  Google Scholar 

  • Gray CL, Ndefo UA (2008) Nebivolol: a new antihypertensive agent. Am J Health Syst Pharm 65(12):1125–1133

    Article  CAS  PubMed  Google Scholar 

  • Hall JE (2003) The kidney, hypertension, and obesity. Hypertension 41(part 2):625–633

    Article  PubMed  CAS  Google Scholar 

  • Hanley AJ, Zinman B, Sheridan P et al (2010) Effect of rosiglitazone and ramipril on b-cell function in people with impaired glucose tolerance or impaired fasting glucose. Diabetes Care 33:608–613

    Article  CAS  PubMed  Google Scholar 

  • Hansson L, Lindholm LH, Ekbom T et al The Swedish STOP 2 study (1999) Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity, the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 354:1751–1756. STOP 2

    Google Scholar 

  • Heerspink HL, de Zeeuw D (2010) Composite renal endpoints: was ACCOMPLISH accomplished? Lancet 375(9721):1140–1142

    Article  PubMed  Google Scholar 

  • Hegholm A, Kristensen KS, Madsen NH et al (1992) White coat hypertension diagnosed by 24-hr ambulatory monitoring. Am J Hypertens 5:64–70

    Google Scholar 

  • Jamerson KA, Bakris GL, Weber MA (2010) 24-Hour ambulatory blood pressure in the ACCOMPLISH Trial. N Engl J Med 363(1):98

    Article  CAS  PubMed  Google Scholar 

  • Kaplan NM (2007) Vascular outcome in type 2 diabetes: an ADVANCE? Lancet 370(9590):804–805

    Article  PubMed  Google Scholar 

  • Kaplan NM (2008) Beta-blockers in hypertension: adding insult to injury. J Am Coll Cardiol 52(18):1490–1491

    Article  PubMed  Google Scholar 

  • Kendall MJ, Cohen JD (1999) β-Blockers as first-line agents for hypertension in the elderly. JAMA 281:131–133

    Article  CAS  PubMed  Google Scholar 

  • Kendall MJ, Cohen JD (1999) β-Blockers as first-line agents for hypertension in the elderly. JAMA 281:131–133

    Article  CAS  PubMed  Google Scholar 

  • Khan M Gabriel (1988) Hypertension. In: Cardiac drug therapy, 2nd edn. WB Saunders, London, p 82

    Google Scholar 

  • Khan M Gabriel (1996) Angina. In: Heart disease diagnosis and therapy, a practical approach. Williams and Wilkins, Baltimore, p 157

    Google Scholar 

  • Khan M Gabriel (2003a) Hypertension. In: Cardiac drug therapy, 6th edn. WB Saunders, Philadelphia, p 182

    Google Scholar 

  • Khan M Gabriel (2003b) Hypertension. In: Cardiac drug therapy, 6th edn. WB Saunders, Philadelphia, p 502

    Google Scholar 

  • Khan M Gabriel (2005) Angina. In: Heart disease diagnosis and therapy, a practical approach, 2nd edn. Humana, Totowa, pp 150–152

    Google Scholar 

  • Khan M Gabriel (2007a) Beta blocker controversies. In: Cardiac drug therapy, 7th edn. Humana/Springer, New York, p 103

    Google Scholar 

  • Khan M Gabriel (2007b) Beta blocker controversies. In: Cardiac drug therapy, 7th edn. Humana/Springer, New York, p 38

    Google Scholar 

  • Kokkinos P, Chrysohoou C, Panagiotakos D et al (2006) Beta-blockade mitigates exercise blood pressure in hypertensive male patients. J Am Coll Cardiol 47:794–798

    Article  CAS  PubMed  Google Scholar 

  • Kostis JB (2008) Treating hypertension in the very old. N Engl J Med 358:1958–1960

    Article  CAS  PubMed  Google Scholar 

  • Law MR, Morris JK, Wald NJ (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:b1665

    Article  CAS  PubMed  Google Scholar 

  • Maffei A, Lembo G (2009) Nitric oxide mechanisms of nebivolol. Ther Adv Cardiovasc Dis 3(4):317–327

    Article  PubMed  Google Scholar 

  • Mancia G, Laurent S, Agabiti-Rosei E et al (2009) Reappraisal of European guidelines on hypertension management: a European society of hypertension task force document. J Hypertens 27: 2121–2158

    Article  CAS  PubMed  Google Scholar 

  • Materson BJ, Reda DJ (1994) Correction: single-drug therapy for hypertension in men. N Engl J Med 330:1689

    Article  CAS  PubMed  Google Scholar 

  • Materson BJ, Reda D, Freiss ED, Henderson WG (1988) Cigarette smoking interferes with treatment of hypertension. Arch Intern Med 148:2116

    Article  CAS  PubMed  Google Scholar 

  • Materson BJ, Reda DJ, Cushman WC et al (1993) Single drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med 328:914

    Article  CAS  PubMed  Google Scholar 

  • Mazza A, Gil-Extremera B, Maldonato A, Toutouzas T, Pessina AC (2002) Nebivolol vs. amlodipine as first-line treatment of essential arterial hypertension in the elderly. Blood Press 11:182–188

    Article  CAS  PubMed  Google Scholar 

  • Messerli FH, Bangalore S (2009) Editorial antihypertensive efficacy of aliskiren; is hydrochlorothiazide an appropriate benchmark? Circulation 119:371–373

    Article  PubMed  Google Scholar 

  • Messerli FH, Grossman E, Goldbourt U (1998) Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? JAMA 279:1903–1907

    Article  CAS  PubMed  Google Scholar 

  • Mosso L, Carvajal C, González A, Barraza A, Avila F, Montero J, Huete A, Gederlini A, Fardella CE (2003) Primary aldosteronism and hypertensive disease. Hypertension 42:161–165

    Article  CAS  PubMed  Google Scholar 

  • Münzel T, Gori T (2009) Nebivolol: the somewhat-different β-adrenergic receptor blocker. Am Coll Cardiol 54(16):1491–1499

    Article  CAS  Google Scholar 

  • Murray C, Shorten G (2001) Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension: review article. N Engl J Med 345:1548

    Article  PubMed  Google Scholar 

  • Neutel JM, Smith DHG, Ram CVS (1993) Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents. Am J Med 94:181

    Article  CAS  PubMed  Google Scholar 

  • Nishizaka MK, Zaman MA, Calhoun DA (2003) Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens 16:925–930

    Article  CAS  PubMed  Google Scholar 

  • Nissen SE (2010) Angiotensin-receptor blockers and cancer: urgent regulatory review needed. The Lancet Oncology, Early Online Publication, doi:10.1016/S1470-2045(10)70106-6

    PubMed  Google Scholar 

  • Norwegian Multicentre Group (1981) Timolol induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304:801–807

    Article  Google Scholar 

  • Pitt B (1992) The role of beta-adrenergic blocking agents in preventing sudden cardiac death. Circulation 85(I Suppl):107

    Google Scholar 

  • Pitt B, Reichek N, Willenbrock R et al (2003a) Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 108:1831–1838

    Article  CAS  PubMed  Google Scholar 

  • Riess W, Dubach UC, Burckhardt D, Theobald W, Vuillard P, Zimmerli M (1977) Pharmacokinetic studies with chlorthalidone (Hygroton) in man. Eur J Clin Pharmacol 12:375–382

    Article  CAS  PubMed  Google Scholar 

  • Sarafidis PA, Bakris GL (2008) Resistant hypertension an overview of evaluation and treatment. J Am Coll Cardiol 52(22):1749–1757

    Article  PubMed  Google Scholar 

  • Schmieder RE, Philipp T, Guerediaga J et al (2009) Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide. Circulation 119:417–425

    Article  CAS  PubMed  Google Scholar 

  • Sipahi I, Debanne SM, Rowland DY (2010) Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. The Lancet Oncology, Early Online Publication, doi:10.1016/S1470-2045(10)70106-6

    PubMed  Google Scholar 

  • Spence JD, Sibbaks WJ, Cape RD (1980) Direct indirect and mean blood pressures in hypertensive patients; the problem of cuff artifact due to arterial wall stiffness, and a partial solution. Clin Invest Med 2:165–173

    Google Scholar 

  • Staessen JA, Wang J-G, Thijs L (2001) Cardiovascular protection and blood pressure reduction: a metaanalysis. Lancet 358:1305

    Article  CAS  PubMed  Google Scholar 

  • Staessen JA, Wang J-G, Thijs L (2003) Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens 21:1055–1076

    Article  CAS  PubMed  Google Scholar 

  • The DREAM Trial Investigators (2006) Effect of ramipril on the incidence of diabetes. N Engl J Med 355:1551–1562

    Article  Google Scholar 

  • Tuncer M, Fettser DV, Gunes Y et al (2008) Comparison of effects of nebivolol and atenolol on P-wave dispersion in patients with hypertension (in Russian). Kardiologiia 48:42–45

    CAS  PubMed  Google Scholar 

  • Tzemos N, Lim PO, MacDonald TM (2001) Nebivolol reverses endothelial dysfunction in essential hypertension. Circulation 104:511–515

    Article  CAS  PubMed  Google Scholar 

  • van Nueten L, Taylor FR, Robertson JI (1998) Nebivolol vs. atenolol and placebo in essential hypertension: a double-blind randomised trial. J Hum Hypertens 12:135–140

    Article  PubMed  CAS  Google Scholar 

  • Weber MA, Black H, Bakris G et al (2009) A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial. The Lancet 374(9699):1423–1431

    Google Scholar 

  • Weber MA, Materson BJ (2010) Hypertension guidelines: a major reappraisal critically examines the available evidence. J Clin Hypertens 12(4):229–236

    Article  Google Scholar 

  • Yiannakopoulou ECh, Papadopulos JS, Cokkinos DV, Mountlkalakis TD (2005) Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil 12:243–249

    Article  PubMed  Google Scholar 

  • Zweifler AJ, Shahab ST (1993) Pseudohypertension: a new assessment. J Hypertens 11:1–6

    Article  CAS  PubMed  Google Scholar 

Suggested Reading

  • Chertow GM, Chang TI (2010) Hospitalized hypertension, and cardiovascular events: cause or consequence? Circulation 121:2160–2161

    Article  PubMed  Google Scholar 

  • Devlin JW (2004) Fenoldopam versus nitroprusside for the treatment of hypertensive emergency. Ann Pharmacother 38(5):755–759

    Article  CAS  PubMed  Google Scholar 

  • Mann JFE (2010) What's new in hypertension 2009? Nephrol Dial Transpl 25(1):37–41

    Article  Google Scholar 

  • Maron BA, Leopold JA (2010) Aldosterone receptor antagonists: effective but often forgotten. Circulation 121:934–939

    Article  PubMed  Google Scholar 

  • Pierdomenico SD, Lapenna D, Bucci A, Di Tommaso R, Di Mascio R, Manente BM, Caldarella MP, Neri M, Cuccurullo F, Mezzetti A (2005) Cardiovasular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens 18:1422–1428

    Article  PubMed  Google Scholar 

  • Pitt B (2009) RAAS inhibition/blockade in patients with cardiovascular disease: implications of recent large-scale randomised trials for clinical practice. Heart 95:1205–1208

    Article  CAS  PubMed  Google Scholar 

  • Pitt B, Bakris G, Ruilope LM et al (2008) Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS). Circulation 118:1643–1650

    Article  CAS  PubMed  Google Scholar 

  • Sacks FM, Campos H (2010) Dietary therapy in hypertension. N Engl J Med 362:2102–2112

    Article  CAS  PubMed  Google Scholar 

  • Saha C, Eckert GJ, Ambrosius WT, Chun TY, Wagner MA, Zhao Q, Pratt JH (2005) Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension. Hypertension 46:481–487

    Article  CAS  PubMed  Google Scholar 

  • Staessen JA, Richart T, Wang Z, Thijs L (2010) Implications of recently published trials of blood pressure lowering drugs in hypertensive or high-risk patients. Hypertension 55:819–831

    Article  CAS  PubMed  Google Scholar 

  • Szczech LA, Granger CB, Dasta JF et al For the Studying the Treatment of Acute Hypertension Investigators (2010) Acute kidney injury and cardiovascular outcomes in acute severe hypertension. Circulation 121:2183–2191

    Google Scholar 

  • Takeuchi F, Isono M, Katsuya T, Yamamoto K, Yokota M, Sugiyama T, Nabika T, Fujioka A, Ohnaka K, Asano H, Yamori Y, Yamaguchi S, Kobayashi S, Takayanagi R, Ogihara T, Kato N (2010) Blood pressure and hypertension are associated with 7 loci in the Japanese population. Circulation 121:2302–2309

    Article  PubMed  Google Scholar 

  • The ACCORD Study Group (2010) Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 362:1575–1585

    Article  CAS  Google Scholar 

  • Weiss SA, Blumenthal RS, Sharrett AR et al (2010) Exercise blood pressure and future cardiovascular death in asymptomatic individuals. Circulation 121:2109–2116

    Article  PubMed  Google Scholar 

Case Studies

  • ALLHAT Collaborative Research Group (2000) Major cardiovascular events in hypertensive patients randomized to doxazosin vs. chlorthalidone: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALLHAT Collaborative Research Group. JAMA 283:1967–1975, ALLHAT

    Article  Google Scholar 

  • ALLHAT: Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981–2997, ALLHAT

    Article  Google Scholar 

  • ASCOT-BPLA: Dahlof B, Sever PS, Poulter NR et al For the ASCOT Investigators (2005) Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm a multicentre randomised controlled trial. Lancet 366:895–906. ASCOT-BPLA

    Google Scholar 

  • Bakris GL, Sarafidis PA, Weir MR et al (3 April 2010) Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet 375(9721):1173–1181

    Article  CAS  PubMed  Google Scholar 

  • Beta-Blocker Heart Attack Trial Research Group (1982) A randomised trial of propranolol in patients with acute myocardial infarction, I: mortality results. JAMA 247:1707–1714. BHAT

    Article  Google Scholar 

  • Brown MJ, Christopher RP, Castaigne A (2000) Morbidity and mortality in patients randomized to double blind treatment with a long acting calcium channel blocker or diuretic in the international nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 356:366, INSIGHT

    Article  CAS  PubMed  Google Scholar 

  • Dahlof B, Lindholm LH, Hansson L et al (1991) Morbidity and mortality in the Swedish Trial in Old Patients with hypertension (STOP hypertension). Lancet 338:1281–1285, STOP

    Article  CAS  PubMed  Google Scholar 

  • Flather MD, Shibata MC, Coats AJS et al (2005) SENIORS investigators randomized trial to determine the effect of nebivolol on mortality and hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26:215–225. SENIORS

    Article  CAS  PubMed  Google Scholar 

  • Hansson L, Lindholm LH, Niskanen L et al (1999) Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the captopril prevention project. Lancet 353:611–616, CAPP

    Article  CAS  PubMed  Google Scholar 

  • Jamerson K, Weber MA, Bakris GL et al For the ACCOMPLISH trial investigators (2008) Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 359:2417–2428. ACCOMPLISH

    Google Scholar 

  • MRC: MRC Working Party (1992) Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 304:405–412, MRC

    Article  Google Scholar 

  • ONTARGET: The ONTARGET Investigators (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358:1547–1559, ONTARGET

    Article  Google Scholar 

  • Packer M, O’Connor CM, Ghali JK et al For the Prospective Randomized Amlodipine Survival Evaluation (PRAISE) (1996) Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 335:1107. PRAISE

    Article  CAS  PubMed  Google Scholar 

  • Packer M, Coats JS, Fowler MB et al For the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651. COPERNICUS

    Article  CAS  PubMed  Google Scholar 

  • Patel A, MacMahon S, Chalmers J et al For ADVANCE Collaborative Group (2007) Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomized controlled trial. Lancet 370:829–840. ADVANCE

    Article  CAS  PubMed  Google Scholar 

  • Pepine CJ, Handberg EM, Cooper-DeHoff RM et al (2003) A calcium antagonist vs. a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil Trandolapril Study (INVEST): a randomized controlled trial. JAMA 290:2805–2816. INVEST

    Google Scholar 

  • Pitt B, Remme W, Zannad F et al (2003b) Eplerenone post-acute myocardial infarction heart failure efficacy and survival study investigators: eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309–1321, EPHESUS

    Article  CAS  PubMed  Google Scholar 

  • PROGRESS Collaborative Group (2001) Randomized trial of a perindopril-based blood pressure lowering regimen among individuals with previous stroke or transient ischaemic attack. Lancet 358:1033. PROGRESS

    Google Scholar 

  • SHEP Cooperative Study Group et al (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Programs (SHEP). JAMA 265:3255. SHEP

    Google Scholar 

  • Staessen JA, Fagard R, Thijs L et al (1997) Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension: the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 350:757–764. Syst-Eur

    Google Scholar 

  • The CAPRICORN Randomized Trial (2001) Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction. Lancet 357:1385. CAPRICORN

    Article  Google Scholar 

  • UK Prospective Diabetes Study Group et al (1998) Efficacy of atenolol and captopril in reducing risk of microvascular and macrovascular complications in type II diabetes. BMJ 317:713. UKPDS

    Google Scholar 

  • van Veldhuisen DJ, Cohen-Solal A, Bohm M et al (2009) SENIORS investigators, Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with Heart Failure). J Am Coll Cardiol 53:2150–2158. SENIORS

    Article  PubMed  CAS  Google Scholar 

  • Yusuf S, Diener HC, Sacco RL et al For the PRoFESS Study Group (2008) Telmisartan to prevent recurrent stroke and cardiovascular events. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 359:1225–1237. PRoFESS

    Google Scholar 

  • Yusuf S, Teo K, Anderson C et al For the TRANSCEND Investigators (2008) Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet 372:1174–1183. TRANSCEND

    Google Scholar 

Download references

Editor information

Editors and Affiliations

  1. Cardiologist, The Ottawa Hospital, Ottawa, Canada

    M. Gabriel Khan MD, FRCP [London], FRCP[C], FACC

  2. Associate Professor of Medicine, University of Ottawa,  ,  

    M. Gabriel Khan MD, FRCP [London], FRCP[C], FACC

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media LLC

About this entry

Cite this entry

(2011). Hypertension. In: Khan, M.G. (eds) Encyclopedia of Heart Diseases. Humana Press. https://doi.org/10.1007/978-1-60761-219-3_64

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-219-3_64

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60761-218-6

  • Online ISBN: 978-1-60761-219-3

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation